Masked hypertension in untreated and treated patients with diabetes mellitus: attractive but questionable interpretations..
Hypertension. 62(4), e21.
(2013). Editorial: interventional management of hypertension and cardiovascular disease: the beginning of a new era?.
Curr Vasc Pharmacol. 12(1), 2-3.
(2014). Splenic-gonadal fusion in a 6-year-old boy, confirmed by Tc-99m sulfur colloid scanning..
Clin Nucl Med. 36(11), e165-7.
(2011). Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions..
Expert Opin Ther Targets. 13(4), 413-25.
(2009). Is 0.75 mm Breslow thickness the correct cut-off point for performing sentinel node biopsy in patients with melanoma?.
Hell J Nucl Med. 13(3), 253-6.
(2010). A novel quantitative method for assessing the therapeutic response to Tafamidis therapy in patients with cardiac TTR amyloidosis. A preliminary report..
Hell J Nucl Med. 25(2), 216-219.
(2022). Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes..
N Engl J Med. 378(10), 967.
(2018). Renal nerve ablation for resistant hypertension: the dust has not yet settled..
J Clin Hypertens (Greenwich). 16(6), 399-400.
(2014). Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective..
J Hypertens. 30(5), 874-6.
(2012). Psoriasis and Cardiovascular Disease: Two Sides of the Same Coin?.
Angiology. 69(1), 5-9.
(2018). Renal sympathetic denervation: the jury is still out..
Lancet. 376(9756), 1878-80.
(2010). Dual task performance of working memory and postural control in major depressive disorder..
Neuropsychology. 26(1), 110-8.
(2012). Telmisartan for prevention of cardiovascular events..
N Engl J Med. 360(3), 302; author reply 303.
(2009). Renal sympathetic denervation and systemic hypertension..
Am J Cardiol. 105(4), 570-6.
(2010). Gender differences in hypertension: myths and reality..
Curr Hypertens Rep. 15(4), 321-30.
(2013). Peripheral arterial stiffness as a surrogate of central hemodynamics: A new era for cardiovascular risk estimation?.
J Clin Hypertens (Greenwich). 20(3), 469-471.
(2018). Combination of SGLT-2 inhibitors and GLP-1 receptor agonists: potential benefits in surrogate and hard endpoints..
Curr Pharm Des.
(2018). Working memory and postural control: adult age differences in potential for improvement, task priority, and dual tasking..
J Gerontol B Psychol Sci Soc Sci. 64(2), 193-201.
(2009). Obstructive sleep apnea, hypertension, and fibrin clot properties: a novel pathogenetic link with cardiovascular disease?.
J Hypertens. 35(5), 950-952.
(2017). Unusually seen pattern of Tc-DPD soft tissue uptake in a patient with AL amyloidosis. Is it an amyloid type indicator in specific cases?.
Hell J Nucl Med. 25(3), 323-325.
(2022). Screening for Primary Aldosteronism: Whom and How?.
J Clin Hypertens (Greenwich). 17(7), 547-8.
(2015). Renal sympathetic denervation in hypertension..
Curr Opin Nephrol Hypertens. 20(6), 647-53.
(2011). Incidence of reversible defect seen on myocardial perfusion scintigraphy using dipyridamole pharmacologic test early after primary percutaneous coronary intervention: how safe is it to perform this protocol?.
Hellenic J Cardiol. 55(6), 492-8.
(2014). Arterial Stiffness and Emerging Biomarkers: Still a Long Journey to Go..
Angiology. 66(10), 901-3.
(2015). Blood pressure and cardiovascular outcomes: a closer look..
Lancet. 389(10076), 1295-1296.
(2017).